IQVIA Holdings Inc (QTS) Stock Forecast, Price Targets and Analysts Predictions

QTS Analyst Ratings

Strong Buy

14 Buy

1 Hold

0 Sell

Based on 15 analysts giving stock ratings to

IQVIA

Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

QTS Stock 12 Month Forecast

Average Price Target

―

Based on 15 Wall Street analysts offering 12 month price targets for IQVIA Holdings in the last 3 months. The average price target is CHF241.30 with a high forecast of CHF286.79 and a low forecast of CHF224.44. The average price target represents a ― change from the last price of ―.

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

Highest Price TargetCHF286.79

Average Price TargetCHF241.30

Lowest Price TargetCHF224.44

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ryan Halsted

RBC Capital

CHF265.17

Buy

―

Reiterated

10/06/26

RBC Capital Keeps Their Buy Rating on IQVIA Holdings (IQV)

Kevin Caliendo

UBS

CHF286.79

Buy

―

Initiated

09/30/26

Iqvia resumed with a Buy at UBSIqvia resumed with a Buy at UBS

Jailendra Singh

Truist Financial

CHF249.38→CHF273.49

Buy

―

Reiterated

09/28/26

Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR) and IQVIA Holdings (NYSE: IQV)

Kallum Titchmarsh

Morgan Stanley

CHF199.5→CHF224.44

Hold

―

Assigned

09/17/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Veracyte (NASDAQ: VCYT), IQVIA Holdings (NYSE: IQV) and Chemed (NYSE: CHE)

Elizabeth Anderson CFA

Evercore ISI

CHF228.6

Buy

―

Reiterated

08/12/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Ann Hynes

Mizuho Securities

CHF191.19→CHF228.6

Buy

―

Reiterated

07/31/26

Mizuho Securities Remains a Buy on IQVIA Holdings (IQV)

Unknown Analyst

Jefferies

Not Ranked

Jefferies

CHF182.88→CHF241.07

Buy

―

Reiterated

07/29/26

IQVIA Holdings (IQV) Gets a Buy from Jefferies

Luke Sergott

Barclays

CHF174.57→CHF228.6

Buy

―

Reiterated

07/29/26

Iqvia price target raised to $275 from $210 at BarclaysIqvia price target raised to $275 from $210 at Barclays

Casey Woodring

J.P. Morgan

CHF187.03→CHF236.91

Buy

―

Assigned

07/29/26

Iqvia price target raised to $285 from $225 at JPMorganIqvia price target raised to $285 from $225 at JPMorgan

Eric Coldwell

Robert W. Baird

CHF209.48→CHF238.57

Buy

―

Reiterated

07/29/26

Iqvia price target raised to $287 from $252 at BairdIqvia price target raised to $287 from $252 at Baird

Charles Rhyee

TD Cowen

CHF193.68→CHF239.4

Buy

―

Assigned

07/29/26

Analysts Are Bullish on These Healthcare Stocks: Somnomed Limited (SOMNF), IQVIA Holdings (IQV)

Shlomo Rosenbaum

Stifel Nicolaus

CHF182.88→CHF229.43

Buy

―

Reiterated

07/29/26

Iqvia price target raised to $276 from $220 at StifelIqvia price target raised to $276 from $220 at Stifel

Sean Dodge

BMO Capital

CHF174.57→CHF224.44

Buy

―

Reiterated

07/29/26

Iqvia price target raised to $270 from $210 at BMO CapitalIqvia price target raised to $270 from $210 at BMO Capital

Michael Ryskin

Bank of America Securities

CHF203.66→CHF232.75

Buy

―

Reiterated

07/28/26

Analysts Offer Insights on Healthcare Companies: Centene (NYSE: CNC), Incyte (NASDAQ: INCY) and IQVIA Holdings (NYSE: IQV)

Jared Haase

William Blair

―

Buy

―

Reiterated

07/28/26

Jared Haase Reiterates Buy on IQVIA After Q2 Beat, Strong R&D Momentum, and Raised 2026 Outlook

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ryan Halsted

RBC Capital

CHF265.17

Buy

―

Reiterated

10/06/26

RBC Capital Keeps Their Buy Rating on IQVIA Holdings (IQV)

Kevin Caliendo

UBS

CHF286.79

Buy

―

Initiated

09/30/26

Iqvia resumed with a Buy at UBSIqvia resumed with a Buy at UBS

Jailendra Singh

Truist Financial

CHF249.38→CHF273.49

Buy

―

Reiterated

09/28/26

Analysts Offer Insights on Healthcare Companies: Xencor (NASDAQ: XNCR) and IQVIA Holdings (NYSE: IQV)

Kallum Titchmarsh

Morgan Stanley

CHF199.5→CHF224.44

Hold

―

Assigned

09/17/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Veracyte (NASDAQ: VCYT), IQVIA Holdings (NYSE: IQV) and Chemed (NYSE: CHE)

Elizabeth Anderson CFA

Evercore ISI

CHF228.6

Buy

―

Reiterated

08/12/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Ann Hynes

Mizuho Securities

CHF191.19→CHF228.6

Buy

―

Reiterated

07/31/26

Mizuho Securities Remains a Buy on IQVIA Holdings (IQV)

Unknown Analyst

Jefferies

Not Ranked

Jefferies

CHF182.88→CHF241.07

Buy

―

Reiterated

07/29/26

IQVIA Holdings (IQV) Gets a Buy from Jefferies

Luke Sergott

Barclays

CHF174.57→CHF228.6

Buy

―

Reiterated

07/29/26

Iqvia price target raised to $275 from $210 at BarclaysIqvia price target raised to $275 from $210 at Barclays

Casey Woodring

J.P. Morgan

CHF187.03→CHF236.91

Buy

―

Assigned

07/29/26

Iqvia price target raised to $285 from $225 at JPMorganIqvia price target raised to $285 from $225 at JPMorgan

Eric Coldwell

Robert W. Baird

CHF209.48→CHF238.57

Buy

―

Reiterated

07/29/26

Iqvia price target raised to $287 from $252 at BairdIqvia price target raised to $287 from $252 at Baird

Charles Rhyee

TD Cowen

CHF193.68→CHF239.4

Buy

―

Assigned

07/29/26

Analysts Are Bullish on These Healthcare Stocks: Somnomed Limited (SOMNF), IQVIA Holdings (IQV)

Shlomo Rosenbaum

Stifel Nicolaus

CHF182.88→CHF229.43

Buy

―

Reiterated

07/29/26

Iqvia price target raised to $276 from $220 at StifelIqvia price target raised to $276 from $220 at Stifel

Sean Dodge

BMO Capital

CHF174.57→CHF224.44

Buy

―

Reiterated

07/29/26

Iqvia price target raised to $270 from $210 at BMO CapitalIqvia price target raised to $270 from $210 at BMO Capital

Michael Ryskin

Bank of America Securities

CHF203.66→CHF232.75

Buy

―

Reiterated

07/28/26

Analysts Offer Insights on Healthcare Companies: Centene (NYSE: CNC), Incyte (NASDAQ: INCY) and IQVIA Holdings (NYSE: IQV)

Jared Haase

William Blair

―

Buy

―

Reiterated

07/28/26

Jared Haase Reiterates Buy on IQVIA After Q2 Beat, Strong R&D Momentum, and Raised 2026 Outlook

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

PLSEPulse Biosciences

SLDBSolid Biosciences

MDWDMediwound

TRVITrevi Therapeutics

WSTWest Pharmaceutical Services

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering IQVIA Holdings

3 Months

David WindleyJefferies

Success Rate

21/32 ratings generated profit

Average Return

+2.76%

Copying David Windley's trades and holding each position for 3 Months would result in 65.63% of your transactions generating a profit, with an average return of +2.76% per trade.

1 Year

Charles RhyeeTD Cowen

Success Rate

16/20 ratings generated profit

Average Return

+14.24%

Copying Charles Rhyee's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +14.24% per trade.

2 Years

Michael RyskinBank of America Securities

Success Rate

13/15 ratings generated profit

Average Return

+32.01%

Copying Michael Ryskin's trades and holding each position for 2 Years would result in 86.67% of your transactions generating a profit, with an average return of +32.01% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

QTS Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

0

Buy

19

33

20

5

Hold

2

3

1

Sell

0

Strong Sell

0

total

21

36

23

6

In the current month, QTS has received 5 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. QTS average Analyst price target in the past 3 months is 241.30.

Each month's total comprises the sum of three months' worth of ratings.

QTS Financial Forecast

QTS Earnings Forecast

Next quarter’s earnings estimate for QTS is CHF2.72 with a range of CHF2.62 to CHF2.95. The previous quarter’s EPS was CHF2.62. QTS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year QTS has Performed in-line its overall industry.

QTS Sales Forecast

Next quarter’s sales forecast for QTS is CHF3.64B with a range of CHF3.61B to CHF3.66B. The previous quarter’s sales results were CHF3.64B. QTS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year QTS has Performed in-line its overall industry.

QTS Stock Forecast FAQ

What is CH:QTS’s average 12-month price target, according to analysts?

Based on analyst ratings, IQVIA Holdings Inc’s 12-month average price target is 241.30.

What is CH:QTS’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for CH:QTS, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is IQVIA Holdings Inc a Buy, Sell or Hold?

IQVIA Holdings Inc has a consensus rating of Strong Buy, which is based on 14 buy ratings, 1 hold ratings and 0 sell ratings.

What is IQVIA Holdings Inc’s share price target?

The average share price target for IQVIA Holdings Inc is 241.30. This is based on 15 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF286.79 ,and the lowest forecast is CHF224.44. The average share price target represents N/A Increase from the current price of N/A.

What do analysts say about IQVIA Holdings Inc?

IQVIA Holdings Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Streets Analysts.

How can I buy shares of IQVIA Holdings Inc?

To buy shares of CH:QTS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

IQVIA Holdings (QTS) Stock Forecast & Price Target

QTS Analyst Ratings

QTS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering IQVIA Holdings

QTS Analyst Recommendation Trends

QTS Financial Forecast

QTS Earnings Forecast

QTS Sales Forecast

QTS Stock Forecast FAQ

Detailed List of Analyst Forecasts